MedPath

Clinical trial to evaluate the effectiveness and safety of EEFE on cognitive function improvement

Not Applicable
Recruiting
Conditions
Not Applicable
Registration Number
KCT0009469
Lead Sponsor
Ewha Womens University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
80
Inclusion Criteria

1) Those who agree to participate in this study before the test begins and submit a completed informed consent form
2) Men and women aged 55 to under 80 years old
3) Those who complain of subjective cognitive decline

Exclusion Criteria

1) Individuals suspected of having dementia as a result of a neuropsychological examination
2) Those diagnosed with any Axis I psychiatric disorder
3) Those with major medical or surgical diseases requiring immediate treatment, according to their medical history, physical examination, neurological examination, or clinical pathology examination
4) Individuals with contraindications to MRI
5) Individuals with the following diseases:
? Malignant tumors, severe cerebrovascular disease, heart disease, or neuropsychiatric disorders requiring treatment
? A history of traumatic brain injury accompanied by loss of consciousness or convulsions within the past six months
? A history of acute stroke within the last three months
? Uncontrolled hypertension, diabetes, thyroid dysfunction, or kidney failure
? Severe hearing or vision impairment that makes functional evaluation impossible
6) Individuals who have taken anti-dementia drugs or brain metabolism enhancers in the past month
7) Those who have taken psychotropic drugs within the past three months
8) Those who have taken any drug or health functional food related to cognitive function, or foods similar to the test material within the past month
9) Those who have participated in other clinical trials (including human trials) within a month of the start of this human trial
10) Those with hypersensitivity to the ingredients in the investigational products or a history of severe allergic reactions
11) Individuals whom the principal investigator deems unsuitable for participation due to other reasons

Study & Design

Study Type
Interventional Study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath